Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Harkin Exit Intensifies Industry Need To Bolster Supplement Caucus

This article was originally published in The Tan Sheet

Executive Summary

One of DSHEA’s chief authors, Tom Harkin will retire from the Senate after 2014, pressuring supplement industry leaders to identify the next generation of congressional supporters. CRN’s Steve Mister says it will not be possible to replace the duo of Harkin and Orrin Hatch, who is retiring after 2018.

You may also be interested in...



Supplement Self-Regulation Key To Preventing More Oversight – Heinrich

The supplement industry’s new ally in the Senate, Martin Heinrich, encourages industry to increase self-regulation of energy drinks to avoid opening DSHEA to amendments. He also says national GMO labeling legislation could spare industry from a patchwork of state laws.

Supplement Self-Regulation Key To Preventing More Oversight – Heinrich

The supplement industry’s new ally in the Senate, Martin Heinrich, encourages industry to increase self-regulation of energy drinks to avoid opening DSHEA to amendments. He also says national GMO labeling legislation could spare industry from a patchwork of state laws.

New Mexico Sen. Heinrich Voices Supplement Industry Support

The latest potential member of the congressional Dietary Supplement Caucus hails from New Mexico: Democrat Martin Heinrich. Serving his first term in the Senate, Heinrich met industry stakeholders during a reception held by AHPA at Natural Products Expo West.

Related Content

Topics

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel